179 related articles for article (PubMed ID: 21304266)
21. Role of efflux pump inhibitor in decreasing antibiotic cross-resistance of Pseudomonas aeruginosa in a burn hospital in Iran.
Talebi-Taher M; Majidpour َ; Gholami A; Rasouli-Kouhi S; Adabi M
J Infect Dev Ctries; 2016 Jun; 10(6):600-4. PubMed ID: 27367008
[TBL] [Abstract][Full Text] [Related]
22. Comparison of beta-lactams in counter-selecting resistance of Pseudomonas aeruginosa.
Tam VH; Schilling AN; Melnick DA; Coyle EA
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):145-51. PubMed ID: 15964503
[TBL] [Abstract][Full Text] [Related]
23. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
[TBL] [Abstract][Full Text] [Related]
24. Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps.
Azimi L; Rastegar Lari A
Microb Pathog; 2017 Nov; 112():122-125. PubMed ID: 28958949
[TBL] [Abstract][Full Text] [Related]
25. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.
Wolter DJ; Acquazzino D; Goering RV; Sammut P; Khalaf N; Hanson ND
Clin Infect Dis; 2008 Jun; 46(12):e137-41. PubMed ID: 18462098
[TBL] [Abstract][Full Text] [Related]
26. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
Hocquet D; Berthelot P; Roussel-Delvallez M; Favre R; Jeannot K; Bajolet O; Marty N; Grattard F; Mariani-Kurkdjian P; Bingen E; Husson MO; Couetdic G; Plésiat P
Antimicrob Agents Chemother; 2007 Oct; 51(10):3531-6. PubMed ID: 17682106
[TBL] [Abstract][Full Text] [Related]
27. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
Lerner SA; Quinn JP
Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
[TBL] [Abstract][Full Text] [Related]
28. Detection of metallo-β-lactamase-encoding genes among clinical isolates of Pseudomonas aeruginosa in northwest of Iran.
Yousefi S; Farajnia S; Nahaei MR; Akhi MT; Ghotaslou R; Soroush MH; Naghili B; Jazani NH
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):322-5. PubMed ID: 20846807
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Pseudomonas aeruginosa with discrepant carbapenem susceptibility profile.
Pragasam AK; Raghanivedha M; Anandan S; Veeraraghavan B
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():12. PubMed ID: 26911874
[TBL] [Abstract][Full Text] [Related]
30. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
Livermore DM; Yang YJ
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
[TBL] [Abstract][Full Text] [Related]
31. Identification of MupP as a New Peptidoglycan Recycling Factor and Antibiotic Resistance Determinant in
Fumeaux C; Bernhardt TG
mBio; 2017 Mar; 8(2):. PubMed ID: 28351916
[TBL] [Abstract][Full Text] [Related]
32. Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
El'Garch F; Jeannot K; Hocquet D; Llanes-Barakat C; Plésiat P
Antimicrob Agents Chemother; 2007 Mar; 51(3):1016-21. PubMed ID: 17194835
[TBL] [Abstract][Full Text] [Related]
33. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
Cho HH; Kwon GC; Kim S; Koo SH
J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
[TBL] [Abstract][Full Text] [Related]
34. Exposure to ertapenem is possibly associated with Pseudomonas aeruginosa antibiotic resistance.
Cohen MJ; Block CS; Moses AE; Nir-Paz R
Clin Microbiol Infect; 2014 Mar; 20(3):O188-96. PubMed ID: 24102767
[TBL] [Abstract][Full Text] [Related]
35. A mechanism of carbapenem resistance due to a new insertion element (ISPa133) in Pseudomonas aeruginosa.
Ruiz-Martínez L; López-Jiménez L; d'Ostuni V; Fusté E; Vinuesa T; Viñas M
Int Microbiol; 2011 Mar; 14(1):51-8. PubMed ID: 22015702
[TBL] [Abstract][Full Text] [Related]
36. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
Del Barrio-Tofiño E; López-Causapé C; Cabot G; Rivera A; Benito N; Segura C; Montero MM; Sorlí L; Tubau F; Gómez-Zorrilla S; Tormo N; Durá-Navarro R; Viedma E; Resino-Foz E; Fernández-Martínez M; González-Rico C; Alejo-Cancho I; Martínez JA; Labayru-Echverria C; Dueñas C; Ayestarán I; Zamorano L; Martinez-Martinez L; Horcajada JP; Oliver A
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study.
Cavallo JD; Hocquet D; Plesiat P; Fabre R; Roussel-Delvallez M;
J Antimicrob Chemother; 2007 May; 59(5):1021-4. PubMed ID: 17412726
[TBL] [Abstract][Full Text] [Related]
38. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
Wolter DJ; Black JA; Lister PD; Hanson ND
J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
[TBL] [Abstract][Full Text] [Related]
39. Insertion sequence ISRP10 inactivation of the oprD gene in imipenem-resistant Pseudomonas aeruginosa clinical isolates.
Sun Q; Ba Z; Wu G; Wang W; Lin S; Yang H
Int J Antimicrob Agents; 2016 May; 47(5):375-9. PubMed ID: 27061775
[TBL] [Abstract][Full Text] [Related]
40. Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, β-lactam resistance, and peptidoglycan structure.
Ropy A; Cabot G; Sánchez-Diener I; Aguilera C; Moya B; Ayala JA; Oliver A
Antimicrob Agents Chemother; 2015 Jul; 59(7):3925-34. PubMed ID: 25896695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
